Literature DB >> 15006903

4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes.

Claudio A Villalobos1, Paulina Bull, Patricio Sáez, Bruce K Cassels, J Pablo Huidobro-Toro.   

Abstract

1. We recently described that several 2-(2,5-dimethoxy-4-substituted phenyl)ethylamines (PEAs), including 4-I=2C-I, 4-Br=2C-B, and 4-CH(3)=2C-D analogs, are partial agonists at 5-HT(2C) receptors, and show low or even negligible intrinsic efficacy at 5-HT(2A) receptors. These results raised the proposal that these drugs may act as 5-HT(2) antagonists. 2. To test this hypothesis, Xenopus laevis oocytes were microinjected with the rat clones for 5-HT(2A) or 5-HT(2C) receptors. The above-mentioned PEAs and its 4-H analog (2C-H) blocked the 5-HT-induced currents at 5-HT(2A), but not at the 5-HT(2C) receptor, revealing 5-HT(2) receptor subtype selectivity. The 5-HT(2A) receptor antagonism required a 2-min preincubation to attain maximum inhibition. 3. All PEAs tested shifted the 5-HT concentration-response curves to the right and downward. Their potencies varied with the nature of the C(4) substituent; the relative rank order of their 5-HT(2A) receptor antagonist potency was 2C-I>2C-B>2C-D>2C-H. 4. The present results demonstrate that in X. laevis oocytes, a series of 2,5-dimethoxy-4-substituted PEAs blocked the 5-HT(2A) but not the 5-HT(2C) receptor-mediated responses. As an alternative hypothesis, we suggest that the psychostimulant activity of the PEAs may not be exclusively associated with partial or full 5-HT(2A) receptor agonism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006903      PMCID: PMC1574890          DOI: 10.1038/sj.bjp.0705722

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.

Authors:  G A Kennett; M D Wood; F Bright; B Trail; G Riley; V Holland; K Y Avenell; T Stean; N Upton; S Bromidge; I T Forbes; A M Brown; D N Middlemiss; T P Blackburn
Journal:  Neuropharmacology       Date:  1997 Apr-May       Impact factor: 5.250

2.  Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.

Authors:  S M Sorensen; J H Kehne; G M Fadayel; T M Humphreys; H J Ketteler; C K Sullivan; V L Taylor; C J Schmidt
Journal:  J Pharmacol Exp Ther       Date:  1993-08       Impact factor: 4.030

3.  1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.

Authors:  D E Nichols; S Frescas; D Marona-Lewicka; X Huang; B L Roth; G A Gudelsky; J F Nash
Journal:  J Med Chem       Date:  1994-12-09       Impact factor: 7.446

4.  Serotonin 5-HT2 receptor activation potentiates N-methyl-D-aspartate receptor-mediated ion currents by a protein kinase C-dependent mechanism.

Authors:  T Blank; R Zwart; I Nijholt; J Spiess
Journal:  J Neurosci Res       Date:  1996-07-15       Impact factor: 4.164

5.  Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.

Authors:  J L Herndon; A Ismaiel; S P Ingher; M Teitler; R A Glennon
Journal:  J Med Chem       Date:  1992-12-25       Impact factor: 7.446

6.  The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.

Authors:  D Fiorella; R A Rabin; J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

7.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

Authors:  M Pompeiano; J M Palacios; G Mengod
Journal:  Brain Res Mol Brain Res       Date:  1994-04

8.  The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.

Authors:  D W Bonhaus; C Bach; A DeSouza; F H Salazar; B D Matsuoka; P Zuppan; H W Chan; R M Eglen
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

9.  Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.

Authors:  J D Kursar; D L Nelson; D B Wainscott; M Baez
Journal:  Mol Pharmacol       Date:  1994-08       Impact factor: 4.436

Review 10.  Structure-activity relationships at 5-HT1A receptors: binding profiles and intrinsic activity.

Authors:  D L Nelson
Journal:  Pharmacol Biochem Behav       Date:  1991-12       Impact factor: 3.533

View more
  10 in total

1.  Inhibition of SK and M channel-mediated currents by 5-HT enables parallel processing by bursts and isolated spikes.

Authors:  Tara Deemyad; Leonard Maler; Maurice J Chacron
Journal:  J Neurophysiol       Date:  2011-01-05       Impact factor: 2.714

Review 2.  2C or not 2C: phenethylamine designer drug review.

Authors:  Be Vang Dean; Samuel J Stellpflug; Aaron M Burnett; Kristin M Engebretsen
Journal:  J Med Toxicol       Date:  2013-06

3.  Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.

Authors:  Amy J Eshleman; Michael J Forster; Katherine M Wolfrum; Robert A Johnson; Aaron Janowsky; Michael B Gatch
Journal:  Psychopharmacology (Berl)       Date:  2013-10-19       Impact factor: 4.530

Review 4.  Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension.

Authors:  Andrew King; Mirjana Dimovska; Luke Bisoski
Journal:  Curr Hypertens Rep       Date:  2018-02-24       Impact factor: 5.369

Review 5.  Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy.

Authors:  Hans Emanuel Oeri
Journal:  J Psychopharmacol       Date:  2020-09-10       Impact factor: 4.153

6.  Acute Pharmacological Effects of 2C-B in Humans: An Observational Study.

Authors:  Esther Papaseit; Magí Farré; Clara Pérez-Mañá; Marta Torrens; Mireia Ventura; Mitona Pujadas; Rafael de la Torre; Débora González
Journal:  Front Pharmacol       Date:  2018-03-13       Impact factor: 5.810

7.  Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.

Authors:  James D Sexton; Charles D Nichols; Peter S Hendricks
Journal:  Front Psychiatry       Date:  2020-02-11       Impact factor: 4.157

8.  A combined approach using transporter-flux assays and mass spectrometry to examine psychostimulant street drugs of unknown content.

Authors:  Rudolf Rosenauer; Anton Luf; Marion Holy; Michael Freissmuth; Rainer Schmid; Harald H Sitte
Journal:  ACS Chem Neurosci       Date:  2012-12-03       Impact factor: 4.418

9.  Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions.

Authors:  Débora González; Marta Torrens; Magí Farré
Journal:  Biomed Res Int       Date:  2015-10-12       Impact factor: 3.411

Review 10.  Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies.

Authors:  Giulia Costa; Maria Antonietta De Luca; Gessica Piras; Jacopo Marongiu; Liana Fattore; Nicola Simola
Journal:  Neural Regen Res       Date:  2020-05       Impact factor: 5.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.